Miromatrix
Dr. Macenski has almost 30 years of biomedical research and management experience spanning both academia and the medical device industry. He began his career as a psychiatry faculty member at the University of Texas Medical School examining central nervous system drug effects on behavior. After a successful 10-year academic run, Dr. Macenski refocused on clinical research and medical devices. Over the last 15 years he has held various management positions in the orthopedic industry including Clinical Hip Operations Manager, Scientific Affairs Manager for biologic research and an executive leadership position as Global Director of Clinical Affairs at Zimmer Spine. Dr. Macenski was awarded a Ph.D. in behavioral pharmacology from the University of Minnesota. His scholarship is evidenced by authorship of numerous peer-reviewed scientific articles across multiple diverse fields including CNS drug action, human drug abuse, behavioral economics, spine pathology, autologous proteins, and osteoarthritis. He has over 50 conference presentations and is currently an associate editor for The Spine Journal.
This person is not in any offices
Miromatrix
Miromatrix is a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.